CVS Health Potential Turnaround

This is a news story, published by CNBC, that relates primarily to Brian Tanquilut news.

Brian Tanquilut news

For more Brian Tanquilut news, you can click here:

more Brian Tanquilut news

stocks trading & speculation news

For more stocks trading & speculation news, you can click here:

more stocks trading & speculation news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about

CVS Health

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest CVS executives news, rival Walgreens news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

other insurers UnitedHealth Group

CNBC

•

Business

Business & Economics

CVS shares are up 45% this year — here's why it may be starting to turn its business around

Summary

Nutrition label

87% Informative

CVS posted a big beat on fourth-quarter earnings and a 2025 profit outlook that was in line with expectations.

The retail drugstore chain's stock plummeted more than 40% in 2024 after it missed earnings estimates for three straight quarters and withdrew its annual forecast.

CVS isn't out of the woods yet, but some analysts are more optimistic about the company's ability to navigate those challenges moving forward.

CVS ' full-year guidance assumes medical costs will not exceed 2024 levels.

The company last year said it would make significant changes to its Medicare Advantage plans for 2025 .

Jefferies analyst Brian Tanquilut said that is likely due to the company's unique position as a company that owns all three assets.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity